BioAdvance News

Group K Diagnostics and Health Network Laboratories Announce the Commencement of a Clinical Trial

By WebmasterAugust 20, 2019November 1st, 2024No Comments

Group K Diagnostics and Health Network Laboratories Announce the Commencement of a Clinical Trial

Previous PostVenatoRx Pharmaceuticals Expands Development Team as It Advances Its Antibacterial and Antiviral Portfolio
Next PostRenovacor Closes $11 Million Series A Financing to Advance First Gene Therapy for a Rare Cardiovascular Disease